PMID- 30307757 OWN - NLM STAT- MEDLINE DCOM- 20191126 LR - 20201209 IS - 1525-6006 (Electronic) IS - 1064-1963 (Linking) VI - 41 IP - 7 DP - 2019 TI - Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: Leptin, Irisin, LGR4, and Sfrp5. PG - 645-650 LID - 10.1080/10641963.2018.1529779 [doi] AB - The incidence of hypertension and diabetes is increasing, it is reported that adipocytokines might be involved in the pathogenesis of diabetes and hypertension. We aimed to investigate the features of adipocytokines, included of Leptin, Irisin, LGR4, and Sfrp5 in type 2 diabetes mellitus (T2DM) patients with hypertension, simultaneously analyzed the connection of the alteration of adipocytokines with blood pressure and glucose. 424 patients with T2DM and 90 healthy subjects were included in the study. The patients with T2DM were divided into 4 groups based on the blood pressure. The levels of adipocytokines (Leptin, Irisin, LGR4, and Sfrp5) were determined by enzyme-linked immunosorbent assay (ELISA). Significantly higher levels of Leptin and lower levels of Irisin, LGR4 and Sfrp5 were seen in patients with diabetes compared with non-diabetes (P < 0.05), the mean values of Leptin level was ascending and Irisin, LGR4, and Sfrp5 levels were declining with promoting of blood pressure in hypertension as compared to the non-hypertension with diabetic patients. Multiple stepwise linear regression analysis showed that the concentrations of Leptin, Irisin, Sfrp5, and LGR4 were found to be closely associated with the control of blood pressure and glucose. Conclusion: Four adipocytokines might play different roles and closely relate to the occurrence and development of diabetes and hypertension. FAU - Li, Baoxin AU - Li B AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. AD - b Hebei Medical University , Shijiazhuang , Hebei , China. FAU - Yao, Qi AU - Yao Q AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Guo, Shuqin AU - Guo S AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Ma, Shuang AU - Ma S AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Dong, Yuehua AU - Dong Y AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Xin, Huanhuan AU - Xin H AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Wang, He AU - Wang H AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Liu, Lifang AU - Liu L AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Chang, Wenlong AU - Chang W AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. FAU - Zhang, Yunliang AU - Zhang Y AD - a Department of Endocrinology, Baoding NO.1 Central Hospital , Baoding , Hebei , China. LA - eng PT - Journal Article DEP - 20181011 PL - England TA - Clin Exp Hypertens JT - Clinical and experimental hypertension (New York, N.Y. : 1993) JID - 9305929 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Adipokines) RN - 0 (Blood Glucose) RN - 0 (Eye Proteins) RN - 0 (FNDC5 protein, human) RN - 0 (Fibronectins) RN - 0 (LGR4 protein, human) RN - 0 (Leptin) RN - 0 (Membrane Proteins) RN - 0 (Receptors, G-Protein-Coupled) RN - 0 (SFRP5 protein, human) SB - IM MH - Adaptor Proteins, Signal Transducing MH - Adipokines/*blood MH - Adult MH - Aged MH - Blood Glucose/metabolism MH - Blood Pressure MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*blood/complications MH - Eye Proteins/blood MH - Female MH - Fibronectins/blood MH - Humans MH - Hypertension/complications/*physiopathology MH - Leptin/blood MH - Male MH - Membrane Proteins/blood MH - Middle Aged MH - Receptors, G-Protein-Coupled/blood OTO - NOTNLM OT - Diabetes OT - Irisin OT - LGR4 OT - Leptin OT - Sfrp5 OT - hypertension EDAT- 2018/10/12 06:00 MHDA- 2019/11/27 06:00 CRDT- 2018/10/12 06:00 PHST- 2018/10/12 06:00 [pubmed] PHST- 2019/11/27 06:00 [medline] PHST- 2018/10/12 06:00 [entrez] AID - 10.1080/10641963.2018.1529779 [doi] PST - ppublish SO - Clin Exp Hypertens. 2019;41(7):645-650. doi: 10.1080/10641963.2018.1529779. Epub 2018 Oct 11.